Plasma thymidine kinase 1 activity and outcome of ER+HER2-metastatic breast cancer patients treated with palbociclib and endocrine therapy

首页> 外文期刊>Intelligence: A Multidisciplinary Journal >Plasma thymidine kinase 1 activity and outcome of ER+HER2-metastatic breast cancer patients treated with palbociclib and endocrine therapy

【24h】

Plasma thymidine kinase 1 activity and outcome of ER+HER2-metastatic breast cancer patients treated with palbociclib and endocrine therapy

机译：血浆胸苷激酶1患者治疗ER + HER2-转移性乳腺癌患者的活性和结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Intelligence: A Multidisciplinary Journal》 |2020年第2020期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心理学;
关键词

相似文献

外文文献
中文文献
专利

1. Plasma thymidine kinase 1 activity and outcome of ER+HER2-metastatic breast cancer patients treated with palbociclib and endocrine therapy [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：血浆胸苷激酶1患者治疗ER + HER2-转移性乳腺癌患者的活性和结果
2. Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy [J] . Varella Leticia, Eziokwu Akaolisa Samuel, Jia Xuefei, Breast cancer research and treatment. . 2019,第2期

机译：帕尔巴泛菌和内分泌治疗治疗转移性乳腺癌患者的现实世界临床结果和毒性
3. Serum Thymidine Kinase 1 Activity in Solid Tumor (Breast and Colorectal Cancer) Patients Treated With Adjuvant Chemotherapy [J] . BolayirliM., PapilaC., KorkmazG.G., Journal of clinical laboratory analysis. . 2013,第3期

机译：辅助化疗治疗的实体瘤（乳腺癌和大肠癌）患者的血清胸苷激酶1活性
4. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
5. A Retrospective Chart Review on Declination of Endocrine Therapy in Patients with Non-invasive Breast Cancer and Atypical Hyperplasia [D] . Ray, Brittany. 2020

机译：非侵入性乳腺癌和非典型增生患者内分泌治疗衰退的回顾图综述
6. Plasma thymidine kinase 1 activity and outcome of ER+ HER2− metastatic breast cancer patients treated with palbociclib and endocrine therapy [O] . Luc Cabel, Dan Rosenblum, Florence Lerebours, 2020

机译：血浆胸苷激酶1患者患者的血浆胸苷激酶1活性和结果对帕尔博兴氏菌和内分泌治疗治疗的乳腺癌患者
7. Cyclin-dependent kinase 4/6 inhibitors palbociclib or ribociclib combined with endocrine therapy and radiation therapy for patients with metastatic breast cancer [O] . I. Ratosa, E. Scoccimarro, L. Dominici, 2020

机译：细胞周期蛋白依赖性激酶4/6抑制剂Palbociclib或Ribociclib与内分泌治疗和转移乳腺癌患者的放射治疗联合

Plasma thymidine kinase 1 activity and outcome of ER+HER2-metastatic breast cancer patients treated with palbociclib and endocrine therapy

著录项

相似文献

相关主题

期刊订阅